Search

Your search keyword '"Wallentin, Lars"' showing total 4,254 results

Search Constraints

Start Over You searched for: Author "Wallentin, Lars" Remove constraint Author: "Wallentin, Lars"
4,254 results on '"Wallentin, Lars"'

Search Results

4. Genetics of circulating inflammatory proteins identifies drivers of immune-mediated disease risk and therapeutic targets

7. Efficacy and Safety of Non–Vitamin-K Antagonist Oral Anticoagulants Versus Warfarin Across the Spectrum of Body Mass Index and Body Weight: An Individual Patient Data Meta-Analysis of 4 Randomized Clinical Trials of Patients With Atrial Fibrillation

15. Author Correction: Genetics of circulating inflammatory proteins identifies drivers of immune-mediated disease risk and therapeutic targets

17. Emergency department visit for atrial fibrillation: sex differences in treatment and outcomes in the Global RE-LY AF Registry

18. Cardiometabolic Comorbidity Burden and Circulating Biomarkers in Patients with Chronic Coronary Disease in the ISCHEMIA Trials

20. Genetic loci and prioritization of genes for kidney function decline derived from a meta-analysis of 62 longitudinal genome-wide association studies

23. Differential and shared genetic effects on kidney function between diabetic and non-diabetic individuals

25. Randomized Trials Fit for the 21st Century: A Joint Opinion From the European Society of Cardiology, American Heart Association, American College of Cardiology, and the World Heart Federation

27. Cohort Profile: the European Unified Registries On Heart care Evaluation and Randomised Trials (EuroHeart) - Acute Coronary Syndrome and Percutaneous Coronary Intervention

28. Repeated Measurement of the Novel Atrial Biomarker BMP10 (Bone Morphogenetic Protein 10) Refines Risk Stratification in Anticoagulated Patients With Atrial Fibrillation: Insights From the ARISTOTLE Trial

32. Meta-analysis uncovers genome-wide significant variants for rapid kidney function decline

33. Next-Generation Sequencing of CYP2C19 in Stent Thrombosis: Implications for Clopidogrel Pharmacogenomics

34. Cohort profile: the European Unified Registries On Heart Care Evaluation and Randomized Trials (EuroHeart)-acute coronary syndrome and percutaneous coronary intervention

35. Temporal biomarker concentration patterns during the early course of acute coronary syndrome

36. Repeated Measurement of the Novel Atrial Biomarker BMP10 (Bone Morphogenetic Protein 10) Refines Risk Stratification in Anticoagulated Patients With Atrial Fibrillation : Insights From the ARISTOTLE Trial

40. Large-Scale Exome-wide Association Analysis Identifies Loci for White Blood Cell Traits and Pleiotropy with Immune-Mediated Diseases

41. Platelet-Related Variants Identified by Exomechip Meta-analysis in 157,293 Individuals

42. Exome Genotyping Identifies Pleiotropic Variants Associated with Red Blood Cell Traits

45. Genomic and drug target evaluation of 90 cardiovascular proteins in 30,931 individuals

47. Direct Oral Anticoagulants Versus Warfarin in Patients With Atrial Fibrillation: Patient-Level Network Meta-Analyses of Randomized Clinical Trials With Interaction Testing by Age and Sex

49. Outcomes of patients with atrial fibrillation and ischemic stroke while on oral anticoagulation

50. Effects of genetic variation in protease activated receptor 4 after an acute coronary syndrome: Analysis from the TRACER trial

Catalog

Books, media, physical & digital resources